Predicting clearance of I-131 from the patients who receiving radioisoope therapy with I-131

Predicting clearance of I-131 from the patients who receiving radioisoope therapy with I-131 - Predicting clearance of I-131 in RI therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038391

Enrollment

150

Registered

2019-10-25

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received I-131 therapy in Nagasaki University during 2016/6/1 - 2019/8/31

Exclusion criteria

Exclusion criteria: Patinet who are under age of 20.

Design outcomes

Primary

Measure	Time frame
I-131 clearance	—

Countries

Japan

Contacts

Public ContactTakashi Kudo

Nagasaki University Dept.of Radioisotope medicine, Atomic bomb disease institute.

tkudo123@nagasaki-u.ac.jp0958197101

Outcome results